PIK3CB/p110β is a selective survival factor for glioblastoma

BACKGROUND: Glioblastoma (GBM) is difficult to treat. Phosphoinositide 3-kinase (PI3K) is an attractive therapeutic target for GBM; however, targeting this pathway to effectively treat GBM is not successful because the roles of PI3K isoforms remain to be defined. The aim of this study is to determin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Pridham, Kevin J, Le, Lamvy, Guo, Sujuan, Varghese, Robin T, Algino, Sarah, Liang, Yanping, Fajardin, Renee, Rodgers, Cara M, Simonds, Gary R, Kelly, Deborah F, Sheng, Zhi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2018
Ämnen:
Basic and Translational Investigations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5909664/
https://ncbi.nlm.nih.gov/pubmed/29016844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox181
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk